Researchers have converted a blood type A kidney to a blood type O kidney and successfully transplanted it, they reported in Nature Biomedical Engineering, an advance that could reduce wait times for new organs and save lives. Type O patients, who account for more than half of those on kidney waiting lists, can only receive organs from donors with type O blood, yet type O kidneys are often given to...

A new drug lowered blood pressure and improved kidney health markers in high-risk patients. Phase 3 trials will test its long-term effects. Preliminary research suggests that adding the new medication baxdrostat to standard treatment may help lower blood pressure and slow the progression of kidney disease in individuals with chronic kidney disease who also have uncontrolled hypertension. The findings were presented at the American Heart Association’s Hypertension Scientific Sessions 2025. The...

The World Health Organization (WHO) today released its second Global hypertension report, showing that 1.4 billion people lived with hypertension in 2024, yet just over one in five have it under control either through medication or addressing modifiable health risks. The new report – released at an event co-hosted by WHO, Bloomberg Philanthropies, and Resolve to Save Lives during the 80th United Nations General Assembly – also reveals that only...